Investigators discuss the involvement of astrocytic α7nAChRs in the instigation and potentiation of early amyloid-β pathology and explore their potential as a target for future reactive astrocyte-based therapeutics and imaging biomarkers in Alzheimer’s disease.
[Nature Reviews Neurology]
